Loading clinical trials...
Loading clinical trials...
Over the 70-day study period, eligible patients visited the study clinic every 2 weeks (total of 6 visits) and received a 28-day course of aztreonam for inhalation solution (AZLI). The Quality of Life...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Gilead Sciences
NCT06166056 · Bronchiectasis
NCT02779478 · Nontuberculous Mycobacteria, Bronchiectasis
NCT07274631 · Chronic Obstructive Pulmonary Disease, Asthma, and more
NCT07188675 · Bronchiectasis, Functional Inspiratory Muscle Training
NCT07289464 · Non-cystic Fibrosis Bronchiectasis
Birmingham, Alabama
Peoria, Arizona
Phoenix, Arizona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions